Schemes for Pharmaceuticals Manufacturing
The Indian pharmaceutical industry is the 3rd largest in the world by volume. However, despite this achievement, we are highly dependent on imports of basic raw materials, viz., bulk drugs that are used to produce medicines. The Government of India is committed to ensuring the delivery of affordable healthcare in the country as well as ensuring that there is a steady supply of critical drugs. This has resulted in the launch of the Production Linked Incentive Scheme (PLI) for APIs, KSMs and DIs as well as the Scheme for Promotion of Bulk Drug Parks. These schemes have been constructed to incentivize large-scale manufacturing of critical bulk drugs and to build the required infrastructure for developing manufacturing clusters for across India. This aligns with the Government’s mission for self-reliance (atmanirbharta).
